Clinical Trials Logo

Meningioma clinical trials

View clinical trials related to Meningioma.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 3

NCT ID: NCT03190122 Not yet recruiting - Clinical trials for Neurocognitive Outcome Assesment in Patients With Perioptic Meningiomas

Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.

Start date: June 2017
Phase: Phase 4
Study type: Interventional

Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.

NCT ID: NCT02978677 Not yet recruiting - Meningioma Clinical Trials

Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas

PANAMA
Start date: October 2022
Phase: N/A
Study type: Interventional

The trial evaluates the effect of a moderately increased radiation dose in patients with atypical (grade II) and anaplastic (grade III) meningioma after incomplete or no surgery. Endpoint is recurrence-free survival after 5 years.

NCT ID: NCT02939833 Not yet recruiting - Meningiomas Clinical Trials

Effects of Scalp Nerve Blocks on Systemic Inflammation

Start date: January 2017
Phase: N/A
Study type: Interventional

Patients undergoing meningeoma resection surgery will be randomly assigned to two groups. One group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline after anesthesia induction and before skull-pin insertion. Serum levels of TNF-α、IL-6 and IL-1β will be measured and compared at before surgery, 1h, 24h and 72h after surgery, respectively. VAS score, dosage of pain-control medicine and NRS score at the first three days after surgery, ratio of intracranial infection within 30d after surgery, and total hospitalization days and medical expenditure will also be recorded and compared between the two groups.

NCT ID: NCT02084927 Not yet recruiting - Neurologic Deficits Clinical Trials

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

Start date: April 2014
Phase: Phase 1
Study type: Interventional

The aim of the current study is to evaluate, in a prospective cross-over, randomized study, the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic neurological deficits and cognitive impairment after anterior skull base meningioma tumor removal.